Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Bruno Frediani and Enrico Capochiani.
Bruno Frediani
Connection Strength
0.280
Enrico Capochiani
  1. Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol. Front Med (Lausanne). 2020; 7:466.
    View in: PubMed
    Score: 0.224
  2. Efficacy and safety of ruxolitinib for Covid-19 related acute respiratory distress syndrome in a patient with blastic plasmacytoid dendritic cell neoplasm (leukemic variant). Leuk Lymphoma. 2020 12; 61(14):3523-3525.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.